Biogen makes up to $1B deal for secretive anti-inflammatory biotech

Chris Viehbacher, Biogen CEO (Sarah Merians Photography for Endpoints News) June 17, 2026 08:43 PM EDT Deals Bio­gen makes up to $1B deal for se­cre­tive an­ti-in­flam­ma­to­ry biotech Kyle LaHucik Biotech Correspondent Bio­gen will pay as much as $1 bil­lion — “pre­dom­i­nant­ly” in mile­stone pay­ments — to ac­quire a San Diego biotech that has dis­closed lit­tle about its pipeline. … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER